HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
1 - 10 of 30
Dr. Falk is a Clinical Geneticist who serves as executive director of the Mitochondrial Medicine Frontier Program. Her translational research lab investigates the causes and global metabolic consequences of mitochondrial disease, as well as targeted therapies, in C. elegans, zebrafish, mouse, and human tissue models of genetic-based respiratory chain dysfunction.
Dr. Feemster's research includes vaccine acceptance among parents and immunization providers, community-based interventions to improve vaccine uptake, neighborhood factors associated with the incidence of pertussis and influenza, and healthcare-associated respiratory infection in the pediatric ambulatory setting.
Dr. Fein conducts youth violence prevention research and has been the principal investigator (PI) or co-investigator of numerous federally funded projects addressing the youth violence epidemic through mixed-methods research, particularly community-based, participatory research (CBPR). He is currently the PI for a NICHD-funded study looking at the impact of a post-traumatic stress disorder (PTSD) prevention program on assault-injured youth and their families.
Dr. Felix uses molecular, biochemical, cellular and in vivo methods to investigate the pathobiology of leukemias with KMT2A (MLL) translocations. Leukemias with these translocations affect infants and young children or occur as a complication of type II topoisomerase (TOP2) poison chemotherapies used for anti-cancer treatment. She aims to develop better treatment and prevention approaches for these leukemias, which have a poor prognosis.
Dr. Feudtner's research strives to advance the well-being of pediatric patients with complex chronic conditions and serious, often rare, illnesses, and to promote the well-being of their families. Along with his colleagues, Dr. Feudtner is conducting studies focusing on pediatric palliative care, complex care, the impact on families of pediatric serious illness, and pediatric medical ethics.
Dr. Fieldston focuses on evidence-based management aimed at delivering high-value care and the impact of operational issues on patient outcomes. His academic work included investigating associations between patient flow, care models, workload and occupancy levels, and resource utilization on the quality of healthcare delivered to children, particularly those in the hospital, as well as healthcare value and value education.
Dr. Fiks’ research is aimed at improving outcomes for ambulatory pediatric patients through primary care, practice-based scholarship with a focus on improving health and healthcare decision-making through health information technology.